Eisenmenger Syndrome Medication: Diuretics, Cardiac Glycosides, Prostaglandins, Iron Products, Rheumatologics, Other,...
Epoprostenol is a strong vasodilator of all vascular beds. It may decrease thrombogenesis and platelet clumping in the lungs by ... Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003 Mar 1. ... Initiate administration of epoprostenol under close observation in the intensive care unit (ICU), with a right heart flotation ... Ivy DD, Doran A, Claussen L, Bingaman D, Yetman A. Weaning and discontinuation of epoprostenol in children with idiopathic ...
Erythromelalgia: Practice Essentials, Background, Pathophysiology
... along with epoprostenol, alemtuzumab, and fumaric acid. [24] ...
Cor Pulmonale: Overview, Presentation, DDx
Epoprostenol, treprostinil, and bosentan are prostacyclin (PGI2) analogues and have potent vasodilatory properties. [36] ... Of these prostacyclin analogues, epoprostenol has been the most studied; it has been shown to improve survival in idiopathic ... Epoprostenol is administered intravenously (IV). Treprostinil can be administered IV and subcutaneously (SC); the FDA has ...
Group 4 Pulmonary Hypertension: Background, Pathophysiology, Risk Factors
Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2007 Apr. 26 (4 ...
Pulmonary Angiography: Practice Essentials, Lung Scintigraphy, Digital Subtraction Pulmonary Angiography
Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care Med. 2000 Nov. 162(5):1846- ...
Pulmonary Arterial Hypertension: Practice Essentials, Pathophysiology, Etiology
Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care Med. 2000 Nov. 162(5):1846- ... Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll ... Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a ... Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized ...
Scleroderma Treatment & Management: Approach Considerations, Pruritus, Raynaud Phenomenon
Prostaglandin derivatives such as epoprostenol, treprostinil, beraprost, and iloprost * Phosphodiesterase type 5 (PDE-5) ...
Pulmonary Arterial Hypertension Workup: Approach Considerations, Laboratory Studies, Chest Radiography and Computed Tomography
Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care Med. 2000 Nov. 162(5):1846- ... Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll ... Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a ... Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized ...
Persistent Pulmonary Hypertension of the Newborn (PPHN): Practice Essentials, Overview, Etiology
Treatment with epoprostenol in a randomized control trial has shown improvements over placebo in exercise capacity as assessed ... Inhaled epoprostenol for pulmonary hypertension treatment in neonates: a 12-year experience. Am J Perinatol. 2018 Dec 14. [QxMD ... Inhaled prostacyclin (epoprostenol) may act synergistically with iNO to cause effective pulmonary vasodilation. It has been ... 47] In a 2018 retrospective study (2004-2016) that evaluated the efficacy of inhaled epoprostenol in neonates with PPHN, ...
Etiology
Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003 Mar 1. ... Ivy DD, Doran A, Claussen L, Bingaman D, Yetman A. Weaning and discontinuation of epoprostenol in children with idiopathic ... Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous ...
Idiopathic Pulmonary Arterial Hypertension: Practice Essentials, Background, Pathophysiology
Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am ... Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a ...
Pediatric Lung Transplantation: Overview of Pediatric Lung Transplantation, History of Lung Transplantation, Frequency of...
... medical therapy with epoprostenol has delayed or obviated lung transplant. Other pulmonary vasodilators, such as sildenafil and ...
Pulmonary Veno-Occlusive Disease: Background, Pathophysiology, Etiology
Safety and Efficacy of Epoprostenol Therapy in Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis. Circ J ...
Group 2 Pulmonary Hypertension Medication: Diuretics, Anigiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE...
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized ... an increased mortality rate with the use of epoprostenol was observed. The use of prostacylins is contraindicated in PH-LHD ... evaluated the use of epoprostenol infusion with standard of care in patients with advanced heart failure versus standard of ...
Group 2 Pulmonary Hypertension: Background, Pathophysiology, Epidemiology
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized ...